Technology | October 22, 2009

New TomoHD Expands Treatment to Larger Patient Populations

October 22, 2009 - Tomotherapy Inc. has extended its suite of advanced radiation therapy solutions with the addition of the TomoHD treatment system, an efficient, all-purpose new system designed to make it easier for any radiation oncology department to adopt TomoTherapy technology for its patient population. The TomoHD treatment system will be introduced during the upcoming Annual Meeting of the American Society for Radiation Oncology (ASTRO) in booth 1946, Nov. 1-5, in Chicago, Ill.

The new TomoHD treatment system bundles technologies previously available only as options for the TomoTherapy Hi·Art system, as well as new core technologies. The result is a single comprehensive solution that efficiently handles both common and complex clinical indications with ease, broadening the possibilities for any radiation oncology practice and the patients it serves.

The TomoHD treatment system combines TomoHelical and TomoDirect delivery modes. The TomoHelical technique affords continuous 360-degree delivery for gold-standard treatment quality and targeting of complex volumes. The TomoDirect modality — introduced in 2008 — offers a discrete-angle delivery option, with 3-D conformal radiation therapy (3-DCRT) capabilities, for highly efficient treatment of more routine indications. In both delivery modes, clinicians follow the same basic process for planning, imaging and treating targets of up to 160 cm in length with no need to reposition the patient and no need for field junctioning. In addition to extended delivery versatility, the TomoHD treatment system comes complete with 1, 2.5 and 5 cm primary collimator settings that enable users to select the right beam slice width for each case, depending upon conformity and efficiency needs.

The TomoHD treatment system incorporates functional enhancements to significantly improve enterprise-wide integration (including oncology information system connectivity), usability and performance.

The streamlined new design of the TomoHD system gives it the ability to accommodate even smaller bunkers than are currently recommended for the Hi·Art treatment system and its CT scanner-like footprint. The TomoHD treatment system also includes large touch-screen positioning control panels (PCPs), which allow for high-fidelity positioning adjustments of 0.1 mm in X, Y and Z directions, and a hands-free patient unload feature. The TomoHD system also integrates many infrastructure advances to maximize uptime and operational efficiency.

To aid workflow, the TomoHD system includes 14 blade computing power, which facilitates simultaneous optimization of multiple treatment plans — at twice the speed of the Hi·Art treatment system’s standard configuration.

The TomoHD treatment system further increases departmental efficiency with the integration of the Tomo Quality Assurance (TQA) application, a calendar-based productivity tool that simplifies the collection and analysis of system performance information, offering trending and reporting of many parameters that allow physicists to monitor machine performance.

The TomoTherapy radiation therapy platform has been used to extend clinical reach and improve treatment quality at cancer centers around the world. The TomoTherapy platform, which leverages a CT scanner-like ring gantry design, was clinically introduced in July 2003 with the installation of the first TomoTherapy Hi·Art treatment system. Since then, more than 3 million treatment fractions have been delivered on the platform — targeting tumors throughout the body with the aid of daily, pretreatment CT imaging for heightened accuracy and a helical delivery pattern of intensity-modulated radiation therapy (IMRT) for increased precision. During this time, hundreds of scientific papers have also been published documenting the diverse advantages that the TomoTherapy platform offers.

The TomoHD treatment system benefits from the evolution of the TomoTherapy platform and will accommodate future innovations — including the Advanced TomoTherapy Delivery Technique*, a research initiative expected to reduce treatment times by 40 percent to 70 percent, while improving treatment quality.

*Advanced TomoTherapy Delivery Technique is a works-in-progress and not available for sale.

For more information: www.TomoTherapy.com

Related Content

Recommendations address when and how radiation therapy should be used and outline best practices for patient-centered care

Figure 1. The guideline also includes treatment algorithms for initial local management (Figure 1) and local management following an unplanned excision (Figure 2).

News | Radiation Therapy | July 27, 2021
July 27, 2021 — A ...
The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

News | Radiation Oncology | July 21, 2021
July 23, 2021 — Mevion Medical Systems announced that it has delivered the 15-ton compact accelerator to...
ASTRO just issued the following statement in response to the Radiation Oncology Model update in yesterday's HOPPS proposed rule, which compounds significant and detrimental cuts to the cancer care specialty in the proposed 2022 MPFS

Getty Images

News | Radiation Therapy | July 20, 2021
July 20, 2021 — In response to consecutive weeks of proposed...
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s
To help enhance the images and information provided to clinicians for radiation oncology treatment planning, GE Healthcare will integrate Spectronic Medical’s AI-based software with its industry leading AIR Recon DL technology
News | Artificial Intelligence | July 09, 2021
July 9, 2021 — GE Healthcare announced the integration of S...

Image courtesy of RaySearch

Feature | Treatment Planning | July 07, 2021 | Information provided by Grand View Research
The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients’ bones. Once a standard practice, the American Society for Radiation Oncology (ASTRO) has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.

Multiple cancer metastasis to the pelvic bone and femur bones. Getty Images

News | Radiation Therapy | June 24, 2021
June 24, 2021 — An effort by the Michigan Radiation Oncology Quality Consortium ...
 Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G. Hatch Center for Proton Therapy, has opened at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and began treating patients on May 11 with the MEVION S250i Proton Therapy System.

The teams from HCI, U of U and Mevion gather to celebrate the center’s grand opening. Group from left to right: Bill Salter, Ph.D., Senior Director of Radiation Oncology, HCI and Professor and Chief of the Division of Medical Physics, U of U -- Robyn Walker, Sr. Director, Customer Success and Service Operations, Mevion -- James Cooley, Ph.D., Director of Advanced Development, Mevion -- Dennis Shrieve, M.D., Ph.D., Chair in Cancer Research, HCI and Chair of Department of Radiation Oncology, U of U -- Tina Yu, Ph.D., CEO, Mevion -- Michael Good, M.D., Interim President, U of U and Sr. VP for Health Sciences, U of U Health -- Ying Hitchcock, M.D., Professor and Medical Director, Department of Radiation Oncology, U of U. (Photo: Business Wire)

News | Proton Therapy | June 24, 2021
June 24, 2021 — Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin